MODULE ID: SVC-04

Urinalysis & Infection Wing

STATUS: ACTIVE
COLORIMETRIC MODE

Not a diagnosis. Does not replace clinicians. Escalates on red flags.

DIPSTICK ANALYSIS
LEU
Neg
NIT
Neg
PRO
Trace
GLU
Neg
KET
Neg
BIL
Neg
BLD
Neg
SG
1.010
REFERENCE
SAMPLE
PATTERN 1
Normal
PATTERN 2
UTI Suspected
PATTERN 3
Dehydration
PATTERN 4
Proteinuria
01/13MODULE: PROBLEM SPACE

The Problem

Lab urinalysis over-ordered for simple symptoms.

→Routine urinalysis for asymptomatic patients
→Repeat testing without indication
→Lab urinalysis when dipstick sufficient
IMPACT METRICS
45-65%
Reduction in lab urinalysis
$950K
Savings per 10K patients
02/13MODULE: CLINICAL SCENARIOS

When This Service Applies

UTI Symptoms
SCENARIO 1

UTI Symptoms

Presentation
Dysuria, frequency, no fever
Typical
Lab urinalysis + culture
Recommendation
Dipstick first, defer culture if negative
Low
Asymptomatic Screening
SCENARIO 2

Asymptomatic Screening

Presentation
Routine checkup, no symptoms
Typical
Routine urinalysis ordered
Recommendation
Defer, no indication
Very Low
Follow-up Testing
SCENARIO 3

Follow-up Testing

Presentation
Previous normal, stable symptoms
Typical
Repeat lab urinalysis
Recommendation
Dipstick sufficient if stable
Low
03/13MODULE: INPUTS

Input Sources

Dipstick Camera Capture
01

Dipstick Camera Capture

Colorimetric analysis of test strips

RGB analysis, color matching algorithms
Symptoms
02

Symptoms

Structured questionnaire, severity scoring

UTI symptom score, pain scale
04/13MODULE: PROCESSING

Colorimetric Analysis Pipeline

1
Capture
2
Calibrate
3
Match
4
Interpret
COLOR ANALYSIS
  • • RGB color space extraction
  • • Reference strip calibration
  • • Color matching algorithms
  • • Lighting condition normalization
INTERPRETATION
  • • Pattern recognition
  • • Clinical correlation
  • • Risk stratification
  • • Recommendation generation
05/13MODULE: OUTPUT

Engine Output

DIPSTICK INTERPRETATION
LEUNegative
NITNegative
PROTrace
BLDNegative
RECOMMENDATION
Retest / Treat / Escalate

Based on dipstick results and symptoms, determine next step.

Confidence: 85%
NEXT ACTIONS
  • • If positive: Consider treatment
  • • If negative: Defer lab urinalysis
  • • If uncertain: Escalate to clinician
  • • Monitor symptoms if stable
06/13MODULE: IMPACT

Test Minimization Impact

Reduction Metrics

Lab Urinalysis-58%
Urine Cultures-52%
Repeat Visits-35%

Cost Savings

Per Patient
$95
Average reduction
Per 10K Patients
$950K
Annual savings
07/13MODULE: WORKFLOW

Clinical Workflow Integration

1

Patient Presents

UTI symptoms or routine screening

2

Dipstick Capture

Camera captures test strip image

3

Color Analysis

RGB analysis, pattern matching

4

Interpretation

Engine generates recommendation

5

Decision

Retest, treat, or escalate

6

Follow-up

Monitor or defer lab testing

08/13MODULE: SAFETY

Safety Triggers & Escalation

IMMEDIATE ESCALATION
  • ⚠Pregnancy
  • ⚠Fever >38.5°C
  • ⚠Flank pain
  • ⚠Hematuria
  • ⚠Systemic symptoms
CAUTION FLAGS
  • →Recurrent UTIs
  • →Diabetes
  • →Immunocompromised
  • →Recent antibiotics
MONITORING
  • ✓Home care if low risk
  • ✓Reassess in 48h
  • ✓Escalate if worsening
  • ✓Defer lab if stable
09/13MODULE: USE CASES

Real-World Applications

Primary Care
USE CASE 1

Primary Care

Scenario
UTI symptoms evaluation
Traditional
Lab urinalysis + culture
Live Corp
Dipstick first, defer culture if negative
$65 saved per case
Urgent Care
USE CASE 2

Urgent Care

Scenario
Dysuria workup
Traditional
Immediate lab testing
Live Corp
Dipstick screening, selective lab
40% reduction in lab tests
Telemedicine
USE CASE 3

Telemedicine

Scenario
Remote UTI assessment
Traditional
In-person visit required
Live Corp
Camera dipstick, home care
55% avoid visits
Pediatric Care
USE CASE 4

Pediatric Care

Scenario
Child UTI symptoms
Traditional
Routine lab urinalysis
Live Corp
Dipstick screening first
Reduce invasive testing
10/13MODULE: TECHNICAL

Technical Specifications

IMAGE PROCESSING
  • • Resolution: 1080p minimum
  • • Color space: RGB
  • • Calibration: Reference strip
  • • Matching: Pattern recognition
ML MODELS
  • • Color classifier: v1.8.3
  • • Pattern matcher: v2.1.1
  • • Risk calculator: v2.9.2
  • • Confidence: 80% threshold
PERFORMANCE
  • • Processing: <2s
  • • Accuracy: 87% (validated)
  • • Sensitivity: 91%
  • • Specificity: 84%
11/13MODULE: PERFORMANCE

Performance Metrics

87%
Accuracy
Validated on 12K cases
91%
Sensitivity
True positive rate
84%
Specificity
True negative rate
<2s
Processing
Average latency
12/13MODULE: INTEGRATION

Integration & Deployment

API Endpoints

POST /api/urinalysis/assess
Submit dipstick image, symptoms
Returns: Interpretation + recommendation
GET /api/urinalysis/status
Check processing status

Deployment

CLOUD
SaaS, HIPAA-compliant, auto-scaling
ON-PREMISE
Self-hosted, full data control
13/13MODULE: INTEGRATION

How This Service Fits the Engine

1
Inputs
2
Validation
3
Fusion
4
Output
5
Safety

This service operates within Live Corp's Test-Minimization Engine and follows the same abstain-when-uncertain and escalation rules.

Explore Other Services